EBI3 and Chagas disease: Collectively, our data support Ebi3 as a novel regulatory immune-modulator that prevents cardiomyopathy, thus opening a reasonable perspective for the therapeutic manipulation of Ebi3 that could be useful for patients with Chagas disease.